15 September 2026 (Navroze Bureau) : A new super-resolution microscope developed at the Rosalind Franklin Institute in Oxfordshire could give scientists an unprecedented view of the human gut and help them better understand inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.
The instrument, based on stimulated emission depletion (STED) microscopy, can resolve structures at around 20 nanometres—about 10 times finer than conventional light microscopy. Researchers hope the technology will reveal how the gut’s protective barrier breaks down in people with IBD.
Microscope Could Reveal What Happens Inside the Gut
The new microscope allows researchers to examine the organisation of individual proteins at the junctions between intestinal cells.
These junctions help form the barrier that separates the contents of the intestine from surrounding tissue. In IBD, this barrier becomes damaged and more permeable, allowing inflammation to persist.
Scientists say conventional microscopy can show that the barrier is disrupted, but the new technology could reveal how and where the molecular architecture changes at a much smaller scale.
What Is STED Microscopy?
STED, or stimulated emission depletion microscopy, is a super-resolution imaging technique.
The microscope uses a doughnut-shaped depletion laser around a central point of fluorescent light. By suppressing fluorescence around the centre, researchers can capture much finer details than conventional optical microscopes can resolve.
The system can also label and visualise multiple types of biological molecules, including proteins, lipids and glycans, helping researchers examine how different components interact within cells.
Focus on Crohn’s Disease and Ulcerative Colitis
IBD mainly includes Crohn’s disease and ulcerative colitis, chronic conditions that can cause persistent inflammation in the digestive system.
The researchers hope to compare healthy intestinal samples with tissue derived from people with IBD. They want to identify the earliest molecular changes that occur when the protective gut barrier begins to fail.
Patient-Derived Tissue Can Be Studied
One important feature of the new microscope is its ability to work with thicker human samples, including patient-derived intestinal organoids.
The instrument also includes specialised optics to correct image distortion and a temperature-controlled stage, allowing researchers to study living cells and mini-organs under conditions closer to those inside the human body.
Could Lead to More Targeted Treatments
Researchers say the technology could eventually help identify new treatment targets.
Understanding precisely which molecular processes fail when the gut barrier becomes damaged could help scientists design therapies aimed at correcting those specific problems rather than relying only on treatments that broadly suppress inflammation.
However, the microscope is a research tool, not a new treatment or diagnostic test for patients at this stage. Its potential clinical benefits will depend on what scientists discover through future studies.
A Closer Look at the Root Cause
IBD can be difficult to understand because its development involves complex interactions between genetics, the immune system, gut microbes and the intestinal barrier.
The new imaging capability could allow scientists to connect changes at the level of individual proteins and cell junctions with the larger biological processes associated with disease.
Major Investment in UK Research
The microscope was unveiled at the Rosalind Franklin Institute alongside new government-backed funding for scientific research.
Science Minister Chris McDonald announced a five-year investment of about £67.7 million for the Rosalind Franklin Institute, while the Henry Royce Institute is also receiving additional funding as part of the broader research investment.
Why the Breakthrough Matters
IBD affects hundreds of thousands of people in the UK and millions more worldwide. Despite advances in treatment, many patients continue to experience debilitating symptoms, relapses and treatment side effects.
Scientists hope that being able to observe the gut’s molecular architecture at approximately 20-nanometre resolution will provide clues that have remained invisible with conventional imaging techniques.
Research Could Open New Pathways
The immediate goal is not to promise a cure, but to improve scientists’ understanding of how IBD develops.